Fondaparinux is an effective alternative to other non-heparin anticoagulants in the treatment of heparin-induced thrombocytopenia

Abstract

<p>A critical appraisal and clinical application of Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. <em>Blood</em>. 2014;125(6):924-929. doi: <a href="https://doi.org/10.1182/blood-2014-09-599498">10.1182/blood-2014-09-599498</a>.</p>